Kevin Yeaman - Oct 15, 2024 Form 4/A - Amendment Insider Report for Dolby Laboratories, Inc. (DLB)

Role: President and CEO, Director
Signature: /s/ Daniel Rodriguez as Attorney-in-Fact for Kevin Yeaman
Stock symbol: DLB
Transactions as of: Oct 15, 2024
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 11/1/2024, 08:12 PM
Date Of Original Report: Oct 17, 2024
Previous filing: Jun 25, 2024
Next filing: Nov 27, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	DLB	Class A Common Stock						2.56	Oct 15, 2024	By a son

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Remarks:

On October 17, 2024, the reporting person filed a Form 4 which inadvertently left off a holding line reporting the indirect holdings by his son of 2.5592 shares.